Strength Seen in La Jolla Pharmaceutical Co. (LJPC): Stock Shoots 19%

Zacks


La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge 19% on the day. This massive rally can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $8.23 to $9.19 in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, Friday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future

La Jolla Pharmaceutical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other attractive players in the healthcare industry include Synergy Pharmaceuticals, Inc. (SGYP), carrying a Zacks Rank #1 (Strong Buy) along with BioCryst Pharmaceuticals, Inc. (BCRX) and Ohr Pharmaceutical, Inc. (OHRP) with a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>





LA JOLLA PHARMACEUTICAL CO (LJPC): Free Stock Analysis Report

SYNERGY PHARMACEUTICALS DE (SGYP): Free Stock Analysis Report

BIOCRYST PHARMACEUTICALS INC (BCRX): Free Stock Analysis Report

OHR PHARMACEUTICAL INC (OHRP): Free Stock Analysis Report


Zacks Investment Research

View Comments (1)